StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MRDIYT.BK$8.80+1.15%
Fair $8.80+0.0%

MRDIYT.BK

MRDIYT.BK

Consumer Cyclical / Specialty RetailThailand

$8.80

+0.10 (+1.15%)

Fairly Valued+0.0%Fair Value $8.80Fund rank 35/100 · Data gapFallback financials|
SA 59/C
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $4.1B · quality 68.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 65/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

59/100

C

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · MRDIYT.BKLocal privado en este navegador · MRDIYT.BK
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$53.0B

P/E

19.1x

↑

EV/EBITDA

8.6x

↓

ROE

27.1%

↑

Gross Margin

51.7%

↑

Debt/Equity

0.68

↑
52-Week Range$9
$7$10

TradingView lightweight chart

MRDIYT.BK price, volumen y niveles de valoración

Último $8.800Periodo +2.3%
Fair value: $8.800

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+26.4%

FCF CAGR

—

FCF margin

24.8%

FCF / Net income

1.89x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $20.08B · net income $2.63B · FCF $4.98B

2022-FY → 2025-FY

Gross margin

51.7%+5.8% pts

Operating margin

19.2%+3.7% pts

Net margin

13.1%+2.5% pts

FCF margin

24.8%— pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$20.08B$20.08B$16.15B$12.83B$9.94B
Net Income$2.63B$2.63B$1.78B$1.38B$1.05B
EBITDA$6.38B$6.38B$4.80B$2.12B$1.54B
EPS0.460.460.320.230.17
Gross Margin51.7%51.7%49.7%48.6%45.9%
Operating Margin19.2%19.2%16.5%16.5%15.5%
Net Margin13.1%13.1%11.0%10.8%10.6%
Balance Sheet
Debt/Equity0.680.681.882.571.88
Current Ratio2.022.02———
Cash Flow
Free Cash Flow$4.98B$4.98B$3.22B——
Returns
ROE27.1%27.1%37.4%38.5%30.9%
Valuation
P/E19.1319.13———
EV/EBITDA8.578.57———
P/B5.145.14———
Growth & Yield
Revenue Growth24.4%24.4%25.8%29.1%—
EPS Growth44.5%44.5%38.7%31.4%—
Dividend Yield2.8%2.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

19.3%

exigente

EPS terminal req.

$0.78

Spread vs growth

25.2%

5Y implied EPS CAGR

15.5%

exigente

EPS terminal req.

$0.94

Spread vs growth

29.0%

10Y implied EPS CAGR

12.7%

razonable

EPS terminal req.

$1.52

Spread vs growth

31.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total +5.1%

Total return

+5.1%

Start / end P/E

27.0x → 19.1x

EPS bridge

0.32 → 0.46

Residual

-13.0%

EPS growth+44.5%
Multiple rerating-29.2%
Dividend+2.8%
Residual / FX / buybacks / cross-term-13.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.